The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial
Abstract
OBJECTIVE: Growth differentiation factor-15 (GDF-15) is a stress-responsive cytokine that is increased in obesity and established type 2 diabetes. We assessed whether GDF-15 can predict future insulin resistance and impaired glucose control in obese nondiabetic individuals. DESIGN AND METHODS: Plasma GDF-15 concentrations were measured with an automated electrochemiluminescent immunoassay at baseline and after 4 years in 496 obese nondiabetic individuals (52% men, median age 48 years, median body mass index (BMI) 37.6 kg/m(2)) enrolled in the XENical in the prevention of Diabetes in Obese subjects (XENDOS) trial. RESULTS: The median GDF-15 concentration at baseline was 869 ng/l (interquartile range 723-1064 ng/l). GDF-15 was related to body weight, BMI, waist-to-hip ratio, and insulin resistance (homeostasis model assessment of insulin resistance (HOMA-IR)) (all P < 0.01). Changes in GDF-15 from baseline to 4 years were related to changes in body weight, BMI, waist-to-hip ratio, and HOMA-IR (all P < 0.05). Baseline GDF-15 was associated with the risk to have prediabetes or diabetes at 4 years by univariate analysis (odds ratio (OR) FOR 1 unit increase in ln GDF-15, 3.2; 95% confidence interval (CI): 1.7-6.1; P<0.001), and after multivariate adjustment for age, gender, treatment allocation (orlistat vs placebo), BMI, waist-to-hip ratio, and glucose control at baseline (OR 2.2; 95% CI: 1.1-4.7; P=0.026). Similarly, baseline GDF-15 was independently associated with HOMA-IR at 4 years (P=0.024). CONCLUSIONS: This first longitudinal study of GDF-15 in a large cohort of obese individuals indicates that GDF-15 is related to abdominal obesity and insulin resistance and independently associated with future insulin resistance and abnormal glucose control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Altered GDF-15 levels in comparison to matched lean controls have been frequently reported in obese mice, rats, and humans (32, 105).”
From GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin (2020) · cites this paper as [105]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
The global obesity pandemic: shaped by global drivers and local environments
Swinburn, B. A., Sacks, G., Hall, K. D., McPherson, K., Finegood, D. T., Moodie, M. L., & Gortmaker, S. L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60813-1 · Cited by 4,888
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915
Self-citationDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc12-s064 · Cited by 1,539
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily
Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S. M., Pryor, K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11514 · Cited by 1,180
Cited by
Sorted by citations
Items 101–173 of 173
Salman, A., Shaaban, H. E., Salman, M. A., Nasr, S. M. S. E., Soliman, A. M., Salem, A., El-Din, M. T., Mikhail, H. M. S., El-Domiaty, H. F., Allah, N. A., et al. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s304929 · Cited by 10
Roy, D., Purohit, P., Khokhar, M., Modi, A., Shukla, R. K. G., Chaudhary, R., Sankanagoudar, S., & Sharma, P. (2023) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes22010 · Cited by 10
Xu, J., Zhang, R., Millischer, V., Stiernborg, M., Tume, C. E., Mehdinia, S., Barker, P., Yılmaz, Z., Gonçalves, V. F., Lavebratt, C., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03425-0 · Cited by 10
Evaluation of Growth Differentiation Factor-15 in Patients with or without Coronary Artery Disease.
Daloee, S. H., Nakhaei, N., Daloee, M. H., Mahmoodi, M., & Amini, M. (2021) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v92i2.9267 · Cited by 10
Agarwal, R. G., Khokhar, M., Purohit, P., Modi, A., Bajpai, N. K., Bohra, G. K., Garg, M. K., & Sharma, P. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.22.03646-6 · Cited by 10
Sarı, K., Ede, H., Gencer, Z. K., Özkırış, M., Göçmen, A. Y., & İntepe, Y. S. (2015) · BioMed Research International · doi:10.1155/2015/807683 · Cited by 10
Guo, R., Zhang, S., Li, A., Zhang, P., Peng, X., Lu, X., & Fan, X. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107711 · Cited by 9
GDF15: An emerging disease target and biomarker of metabolic diseases
Yang, C., Chen, H., Huang, X., Zhou, L., & Yuan, X. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02636-y · Cited by 10
Is GDF15 a Novel Biomarker to Predict the Development of Prediabetes or Diabetes?
Hur, K. Y. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.6.437 · Cited by 9
Kim, J. M., Back, M. K., Yi, H., Joung, K. H., Kim, H. J., & Ku, B. J. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.1.70 · Cited by 9
Adela, R., Mohammed, S. A., Kanwal, A., Vishwakarma, G., Reddy, P. N., & Banerjee, S. (2016) · Personalized Medicine · doi:10.2217/pme-2016-0030 · Cited by 9
Quantitative Proteomics Evaluation of Human Multipotent Stromal Cell for β Cell Regeneration.
Kuljanin, M., Elgamal, R. M., Bell, G. I., Xenocostas, D., Xenocostas, A., Hess, D. A., & Lajoie, G. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.107 · Cited by 12
Kim, J., Zhao, A., Park, S. H., Han, J., Cheon, D.-H., Ju, S.-H., Jang, Y., Chu, K., Choi, H. J., Kim, J., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01543-9 · Cited by 8
Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication
Lichtenauer, M., Jirak, P., Paar, V., Sipos, B., Kopp, K. L., & Berezin, A. Е. (2021) · Applied Sciences · doi:10.3390/app11104397 · Cited by 8
Yu, L., Zhou, Y., Wang, L., Zhou, X., Sun, J., Xiao, J., Xu, X., Larsson, S. C., Yuan, S., & Li, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.814457 · Cited by 7
Qian, X., He, S., Shen, X., Shi, N., Gong, Q., An, Y., Chen, Y., Wang, J., & Li, G. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101380 · Cited by 7
Şendur, S. N., Fırlatan, B., Baykal, G., Lay, İ., & Erbas, T. A. (2022) · HORMONES · doi:10.1007/s42000-022-00408-4 · Cited by 7
İlhan, H. D., Bilgin, A. B., Toylu, A., Doğan, M. E., & Apaydın, K. C. (2015) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2014.981549 · Cited by 7
Kim, K., & Jang, W. (2021) · BioFactors · doi:10.1002/biof.1817 · Cited by 5
Zhao, W., Li, X., Li, X., Lü, P., Li, Y., Du, Y., He, J., Qin, Y., & Zhang, H. (2023) · European journal of medical research · doi:10.1186/s40001-023-01009-6 · Cited by 5
The GDF15 3′ UTR Polymorphism rs1054564 Is Associated with Diabetes and Subclinical Atherosclerosis
Guardiola, M., Girona, J., Barroso, E., García‐Altares, M., Ibarretxe, D., Plana, N., Ribalta, J., Correig, X., Vázquez‐Carrera, M., Masana, L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211985 · Cited by 5
Li, Y., Wang, Y., Cao, Y., Zhang, X., Dai, W., Zhao, Y., Zhang, L., & Han, X.-F. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s454531 · Cited by 5
Liu, K., Liu, B., Wittert, G., Thompson, C. H., Hutchison, A. T., & Heilbronn, L. K. (2022) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2022.12.001 · Cited by 5
Zhao, W. H., Liu, Y., Cui, Z., Li, X., Guo, H., Chen, X., & Zhang, H. (2025) · Vascular Pharmacology · doi:10.1016/j.vph.2025.107554 · Cited by 4
GDF-15 as an integrative cardiometabolic biomarker
Afzal, O., Afzal, M., Khan, N. H., Altharawi, A., Alamri, M. A., Alossaimi, M. A., Altamimi, A. S., & Goud, P. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.120839 · Cited by 4
Golpasandi, H., Rahimi, R., Kreider, R. B., & Rashidi, M. (2024) · Sport Sciences for Health · doi:10.1007/s11332-024-01270-0 · Cited by 4
Debroy, P., Pike, F., Gawrieh, S., Corey, K. E., Hartig, S. M., Balasubramanyam, A., Ailstock, K., Funderburg, N., & Lake, J. E. (2025) · HIV Medicine · doi:10.1111/hiv.70060 · Cited by 4
Chung, J. O., Chung, M. Y., Park, S., Cho, D. H., & Chung, D. J. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107849 · Cited by 4
Growth differentiating factor-15 and adiposity in young adults: The African-PREDICT study
Vermeulen, B., Gafane-Matemane, L. F., Schutte, A. E., & Kruger, R. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00803-8 · Cited by 4
Integration of Multi-Omics Data Using Probabilistic Graph Models and External Knowledge
Tripp, B. A., & Otu, H. H. (2021) · Current Bioinformatics · doi:10.2174/1574893616666210906141545 · Cited by 4
Shariat, A., Farhangi, M. A., & Zeinalian, R. (2018) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2018.02.003 · Cited by 4
Jianshu, G. A. O., Liu, H., Zhou, Z., & Hu, S. (2025) · Minerva Endocrinology · doi:10.23736/s2724-6507.25.04240-x · Cited by 3
Mei, Y., Li, W., Chen, Z., & Wang, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-98028-6 · Cited by 3
Golpasandi, H., Mirzaei, B., & Golpasandi, S. (2019) · The Journal of Qazvin University of Medical Sciences · doi:10.32598/jqums.23.4.286 · Cited by 3
Yang, P., Zhu, Z., Shi, M., Yin, J., Zang, Y., Zhong, C., Wang, A., Peng, H. Y., Xu, T., Guo, D., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.12.005 · Cited by 3
Berezin, A. Е. (2015) · International Archives of Endocrinology Clinical Research · doi:10.23937/2572-407x.1510002 · Cited by 3
Afify, M. A. M., Elzoghby, D. M. A., Sarhan, A. M., & Eladawy, R. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.273060 · Cited by 3
Dypvik, R., Fjukstad, K. K., Lydersen, S., Berge, T., Tveit, A., Røsjø, H. R., Omland, T., Einvik, G., & Lyngbakken, M. N. (2025) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001365 · Cited by 2
Nikolova, D., Yordanova, S., Kamenov, Z. A., Hristova, J., & Gateva, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15082908 · Cited by 2
Parvaneh, R. R., Vajdi, M., Shiraz, A. N., Khani, M., Farshbaf, S. E., & Farhangi, M. A. (2022) · Nutrition and Health · doi:10.1177/02601060221099716 · Cited by 3
Jung, Y. S., Radhakrishnan, K., Noh, J., Kim, Y., Lee, C., & Choi, H. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112572 · Cited by 2
Growth differentiation factor-15 (GDF-15) for cardiovascular risk assessment
Piechota, W., & Krzesiński, P. (2018) · Pediatria i Medycyna Rodzinna · doi:10.15557/pimr.2018.0001 · Cited by 2
TGF beta Superfamily Cytokine MIC-1/GDF15 in Health and Inflammatory Diseases
Breit, S. N., & Brown, D. A. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_54 · Cited by 2
Response: GDF15 Is a Novel Biomarker for Impaired Fasting Glucose (Diabetes Metab J2014;38:472-9)
Hong, J. H., Ku, B. J., & Shong, M. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.1.84 · Cited by 2
Sardar, M. A., Abbasian, S., Moghavemi, H., & Karabi, M. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149591 · Cited by 1
GDF15: A Novel Insight Into Its Biology and Therapeutic Potential in Obesity
Ahmed, K., Saturnino, A., & Pozzilli, P. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/3024772 · Cited by 1
Guo, T., Chen, L., Sun, W., Yang, H., Li, J., Zhang, X., & Chen, P. (2024) · Schizophrenia · doi:10.1038/s41537-024-00541-6 · Cited by 1
Wood, A. C., & Wang, Z. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_10-1 · Cited by 1
Abdallah, M. A., Hassen, H. A., Abdel-Hafiz, A.-R. M., Fouad, D. A., Youssef, A. A., & Idriss, N. K. (2020) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2020.115620 · Cited by 1
Roy, D., Khokhar, M., Shukla, R. K. G., Sharma, P., & Purohit, P. (2023) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2023.100020 · Cited by 1
Letter: GDF15 Is a Novel Biomarker for Impaired Fasting Glucose (Diabetes Metab J2014;38:472-9)
Koo, B. K. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.1.82 · Cited by 1
Yücel, H. E., & İlanbey, B. (2022) · Medical Science and Discovery · doi:10.36472/msd.v9i6.746 · Cited by 1
Growth Differentiation Factor 15 As Promising Biomarker Of Poor Prognosis In Heart Failure
Berezin, A. Е. (2018) · Journal of Cardiology and Therapy · doi:10.17554/j.issn.2309-6861.2018.05.149 · Cited by 1
TGF-b Superfamily Cytokine MIC-1/GDF15 in Health and Inflammatory Diseases
Breit, S. N., & Brown, D. A. (2014) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_54-1 · Cited by 1
Promising utilities of growth differentiation factor 15 in cardiovascular diseases
Berezin, A. Е. (2018) · Biological Markers and Guided Therapy · doi:10.12988/bmgt.2018.811
(2018) · International journal of research studies in biosciences · doi:10.20431/2349-0365.0602004
Berezin, A. Е., & Berezin, A. A. (2021) · AME Medical Journal · doi:10.21037/amj-20-147
He, X., Su, J., Ma, X., Lu, J., Wang, Y., Yin, J., Bao, Y., Hu, G., & Zhou, J. (2021) · Obesity Medicine · doi:10.1016/j.obmed.2021.100345
Quantitative Proteomics Evaluation of Human Multipotent Stromal Cell for β-Cell RegenerationPreprint
Kuljanin, M., Elgamal, R. M., Bell, G. I., Xenocostas, D., Xenocostas, A., Hess, D. A., & Lajoie, G. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3202934
Wood, A. C., & Wang, Z. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_10
Yılmaz, M. Ö., & Özcan, O. (2022) · Kırıkkale Üniversitesi Tıp Fakültesi Dergisi · doi:10.24938/kutfd.1014625
TGF beta Superfamily Cytokine MIC-1/GDF15 in Health and Inflammatory Diseases
Breit, S. N., & Brown, D. A. (2016) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_54-2
Extracellular vesicles enabling moonlighting proteins
Chitti, S. V., Marzan, A. L., Gummadi, S., & Fonseka, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15719-6.00002-7
Correlation between serum GDF-15 and nutritional state in adults
Ali, A. E., Mohamed, N., Baz, H., & Shenawy, A. E. (2025) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-025-00483-0
Zhao, W., Li, X., Li, X., Peng, L., Li, Y., Du, Y., He, J., Qin, Y., & Zhang, H. (2023) · Figshare · doi:10.6084/m9.figshare.22600165
Oehadian, A., Santoso, P., Prihatni, D., Kartikasari, A., Parwati, I., Handayani, D., Handoyo, T., Sutandiyo, N., Alisjahbana, B., Menzies, D., et al. (2026) · The Clinical Respiratory Journal · doi:10.1111/crj.70195
Yao, S., Peng, B., Ren, L., Yang, Z., Jiang, K., & Sun, C. (2026) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2026.106305
Adipokine-mediated metabolic responses across BMI in acute myocardial infarction
Sunita, S., Syamsunarno, M. R. A. A., Akbar, M. R., Nugrahani, A. D., Sylviana, N., Nugraha, G. I., Ghozali, M., & Achmad, T. H. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06140-w
Lin, Y.-J., Chen, C.-L., Tsai, J., Yang, W., Lee, P., Chen, C., Lin, M., & Yang, P.-J. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08876-y
Kim, J., Lee, A. H., Lee, J. Y., JANG, H.-M., Kim, S. G., Kim, D., & Kim, N. H. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113461
Johnson, W., Norris, T., Hughes, A. D., Hamer, M., Bell, S., & Batty, G. D. (2026) · medRxiv · doi:10.64898/2026.10.08.26365055
Biological functions and emerging interplay of FGF21 and GDF15 in metabolic diseases and aging
Salmón‐Gómez, L., Keipert, S., Catalán, V., Rodrı́guez, A., Becerril, S., Frühbeck, G., & Gómez‐Ambrosi, J. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00627-w
Metadata
- Authors
- Kempf, T., Guba-Quint, A., Torgerson, J., Magnone, M. C., Haefliger, C., Bobadilla, M., & Wollert, K. C.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Wollert, Kai C
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-11
- Volume
- 167
- Issue
- 5
- Pages
- 671-678
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2103530523
- Cited by
- 176
- References
- 34
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 12 · 2023: 6 · 2022: 24 · 2021: 22 · 2020: 19 · 2019: 13 · 2018: 14 · 2017: 5 · 2016: 15 · 2015: 10 · 2014: 6 · 2013: 2 · 2012: 1
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- growth differentiation factor 15, insulin resistance, prediabetes, type 2 diabetes risk, obesity, abdominal obesity, orlistat, HOMA-IR, biomarkers
- MeSH terms
- Adult, Aged, Analysis of Variance, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Longitudinal Studies, Luminescent Measurements, Male, Middle Aged, Obesity, Predictive Value of Tests, Risk Factors, Time Factors, Biomarkers, Body Mass Index, Odds Ratio, Randomized Controlled Trials as Topic, Waist-Hip Ratio, Growth Differentiation Factor 15, Electrochemical Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
